S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Closing prices for crude oil, gold and other commodities
Comprehensive Analysis of PayPal Stock
The Senate passes a reauthorization of a key US surveillance program just after a midnight deadline
Crews turn sights to removing debris from ship's deck in Baltimore bridge collapse cleanup
MarketBeat Week in Review – 4/15 - 4/19
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Closing prices for crude oil, gold and other commodities
Comprehensive Analysis of PayPal Stock
The Senate passes a reauthorization of a key US surveillance program just after a midnight deadline
Crews turn sights to removing debris from ship's deck in Baltimore bridge collapse cleanup
MarketBeat Week in Review – 4/15 - 4/19
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Closing prices for crude oil, gold and other commodities
Comprehensive Analysis of PayPal Stock
The Senate passes a reauthorization of a key US surveillance program just after a midnight deadline
Crews turn sights to removing debris from ship's deck in Baltimore bridge collapse cleanup
MarketBeat Week in Review – 4/15 - 4/19
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Closing prices for crude oil, gold and other commodities
Comprehensive Analysis of PayPal Stock
The Senate passes a reauthorization of a key US surveillance program just after a midnight deadline
Crews turn sights to removing debris from ship's deck in Baltimore bridge collapse cleanup
MarketBeat Week in Review – 4/15 - 4/19

Hepion Pharmaceuticals (HEPA) SEC Filings & 10K Form

$2.01
-0.10 (-4.74%)
(As of 04/19/2024 ET)

Recent Hepion Pharmaceuticals SEC Filings

DateFilerForm TypeView
04/16/2024
3:53 PM
Hepion Pharmaceuticals, Inc. (Filer)
Hepion Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
04/01/2024
3:30 PM
Hepion Pharmaceuticals, Inc. (Filer)
Hepion Pharmaceuticals (Filer)
Form NT 10-K
03/06/2024
3:30 PM
Hepion Pharmaceuticals, Inc. (Issuer)
Hepion Pharmaceuticals (Issuer)
Purcell Michael J. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/06/2024
3:15 PM
Hepion Pharmaceuticals, Inc. (Filer)
Hepion Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/21/2024
7:01 PM
BRANCACCIO JOHN P (Reporting)
Hepion Pharmaceuticals, Inc. (Issuer)
Hepion Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
7:01 PM
Hepion Pharmaceuticals, Inc. (Issuer)
Hepion Pharmaceuticals (Issuer)
Lbiati Kaouthar (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
7:01 PM
Hepion Pharmaceuticals, Inc. (Issuer)
Hepion Pharmaceuticals (Issuer)
JACOB GARY S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
7:01 PM
Block Timothy M. (Reporting)
Hepion Pharmaceuticals, Inc. (Issuer)
Hepion Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
8:02 AM
Hepion Pharmaceuticals, Inc. (Filer)
Hepion Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2024
2:38 PM
ARMISTICE CAPITAL, LLC (Filed by)
Hepion Pharmaceuticals, Inc. (Subject)
Hepion Pharmaceuticals (Subject)
Form SC 13G
01/03/2024
3:30 PM
Hepion Pharmaceuticals, Inc. (Filer)
Hepion Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/07/2023
7:41 AM
Hepion Pharmaceuticals, Inc. (Filer)
Hepion Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/28/2023
5:55 AM
Hepion Pharmaceuticals, Inc. (Issuer)
Hepion Pharmaceuticals (Issuer)
Wijngaard Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2023
11:15 PM
Hepion Pharmaceuticals, Inc. (Filer)
Hepion Pharmaceuticals (Filer)
Form EFFECT
10/03/2023
4:22 PM
Hepion Pharmaceuticals, Inc. (Filer)
Hepion Pharmaceuticals (Filer)
Form D
Notice of Exempt Offering of Securities 
09/20/2023
10:27 AM
Hepion Pharmaceuticals, Inc. (Issuer)
Hepion Pharmaceuticals (Issuer)
Wijngaard Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/19/2023
8:01 AM
Foster Robert T (Reporting)
Hepion Pharmaceuticals, Inc. (Issuer)
Hepion Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/18/2023
7:00 AM
Foster Robert T (Reporting)
Hepion Pharmaceuticals, Inc. (Issuer)
Hepion Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2023
3:40 PM
Hepion Pharmaceuticals, Inc. (Filer)
Hepion Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/24/2023
3:04 PM
Hepion Pharmaceuticals, Inc. (Filer)
Hepion Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/21/2023
3:39 PM
Hepion Pharmaceuticals, Inc. (Filer)
Hepion Pharmaceuticals (Filer)
Form 424B5
07/21/2023
3:41 PM
Hepion Pharmaceuticals, Inc. (Filer)
Hepion Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/14/2023
4:12 PM
Hepion Pharmaceuticals, Inc. (Filer)
Hepion Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
06/22/2023
4:17 PM
Hepion Pharmaceuticals, Inc. (Filer)
Hepion Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/22/2023
12:05 PM
Hepion Pharmaceuticals, Inc. (Filer)
Hepion Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/12/2023
3:17 PM
Hepion Pharmaceuticals, Inc. (Filer)
Hepion Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/10/2023
4:17 PM
Hepion Pharmaceuticals, Inc. (Filer)
Hepion Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/28/2023
3:49 PM
Hepion Pharmaceuticals, Inc. (Filer)
Hepion Pharmaceuticals (Filer)
Form ARS
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:HEPA) was last updated on 4/20/2024 by MarketBeat.com Staff

From Our Partners